Capture.Study vs Medable: A Self-Serve EDC vs an Enterprise DCT Ecosystem
Medable positions itself as a connected operational ecosystem for large, complex trial programs, spanning CTMS, EDC, eTMF, eCOA, eConsent and agentic AI workflow tools, per its own site. Capture.Study is a smaller, self-serve alternative built around EDC, eConsent, ePRO, randomization and an AI study builder for early-phase and mid-size studies. Here is an honest look at where each fits.
Who This Comparison Is For
Medable and Capture.Study are sized for different kinds of programs. This page is useful if:
You want EDC, eConsent and ePRO sized for one study, not an enterprise ecosystem
- Comparing a single self-serve license against a large, multi-product platform
- Want an AI study builder to draft your first pass of visits and forms
You're running a large, multi-vendor decentralized program
- If your program already needs CTMS, eTMF and agentic AI workflow tools together, Medable's broader ecosystem may fit better
- This page tells you honestly where that is true
Quick Comparison Table
| Feature | Capture.Study | Medable |
|---|---|---|
| Self-serve free sandbox, no sales call to start | Enterprise sales process, per Medable's own site | |
| AI drafts CRFs from a protocol or description | Agentic AI workflow agents across CTMS/EDC/eTMF, a different focus, per Medable's own site | |
| eConsent included in the same platform | Included, per Medable's own site | |
| ePRO / ObsRO patient-reported data included | Included, per Medable's own site | |
| Randomization included | Not confirmed as a core module on Medable's public site | |
| Sized for early-phase and mid-size studies | Built for large, multi-vendor enterprise programs, per Medable's own positioning | |
| 21 CFR Part 11-aligned controls | ||
| Full CTMS / eTMF / operational ecosystem | Not included; EDC, eConsent, ePRO and randomization only | Yes, a broader operational ecosystem, per Medable's own site |
We built this table from each vendor's own public positioning. If anything here is out of date, let us know.
Getting Started
Medable's platform breadth means most teams start with an enterprise sales engagement to scope which products they need. Capture.Study lets you build and test your full study in a free sandbox today, with no credit card and no sales call, and you only pay once you go live.
Scope
Medable positions itself as a connected operational ecosystem spanning CTMS, EDC, eTMF, eCOA, eConsent, TeleVisits and agentic AI workflow agents, aimed at large pharma programs running adaptive, decentralized or personalized-medicine trials, per its own site. Capture.Study is intentionally narrower: EDC, eConsent, ePRO, randomization and an AI study builder in one core license, aimed at early-phase and mid-size studies that do not need a full enterprise DCT ecosystem.
Compliance
Medable's compliance posture reflects its scale and enterprise pharma deployments. Capture.Study provides 21 CFR Part 11-aligned controls today, a field-level audit trail that cannot be edited from the app, OTP-verified electronic signatures with countersignature, and role-based access, with documentation to support your own validation on Enterprise plans.
Pricing
Medable does not publish pricing publicly; like most enterprise platforms, it is quoted per program. Capture.Study includes a free sandbox for every study, with paid plans that scale with study size, visible without a sales conversation.
When Medable Is Still the Right Choice
You're running a large, multi-vendor, multi-country program
If your program needs a full DCT ecosystem spanning CTMS, eTMF and agentic AI workflow tools already integrated together, that scale is Medable's stated focus.
You specifically need Medable's operational AI tooling
Teams already integrated with Medable's agentic AI agents across other enterprise systems may not need to switch.
When Capture.Study Is the Better Choice
Your study doesn't need a full DCT ecosystem
Just EDC, eConsent, ePRO and randomization, in one simpler, self-serve platform.
You want to see real pricing before an enterprise sales process
Build and test your entire study in the free sandbox today. No sales call required to see if it fits.
You want AI-assisted form drafting
Upload a protocol or description and review an AI-drafted first pass of your visits and forms.
Frequently Asked Questions
Is Capture.Study a Medable alternative?
For early-phase and mid-size studies, yes. Medable is built as a large, enterprise decentralized-trial ecosystem; Capture.Study is a smaller, self-serve EDC, eConsent, ePRO and randomization platform for teams that do not need that full scope.
Is Capture.Study cheaper than Medable?
We cannot confirm Medable's exact pricing since, like most enterprise platforms, it is quoted through a sales conversation. Capture.Study's free sandbox lets you build your real study and see the actual cost before you decide, with no setup fee.
Can I try Capture.Study before deciding?
Yes. The free sandbox includes every feature with sample data, no credit card and no time limit, so you can test it against your own protocol.
Is Capture.Study 21 CFR Part 11-aligned like Medable?
Yes. Capture.Study provides a field-level audit trail, OTP-verified electronic signatures with countersignature, and role-based access control, with documentation to support sponsor validation on Enterprise plans.
See If Capture.Study Fits Your Study
Free sandbox with no time limit. Build your study and test everything before paying a dollar.
No credit card required. No sales calls.